BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 32293552)

  • 1. Functional and genomic characterization of three novel cell lines derived from a metastatic gallbladder cancer tumor.
    García P; Bizama C; Rosa L; Espinoza JA; Weber H; Cerda-Infante J; Sánchez M; Montecinos VP; Lorenzo-Bermejo J; Boekstegers F; Dávila-López M; Alfaro F; Leiva-Acevedo C; Parra Z; Romero D; Kato S; Leal P; Lagos M; Roa JC
    Biol Res; 2020 Apr; 53(1):13. PubMed ID: 32293552
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Establishment and characterization of 38 novel patient-derived primary cancer cell lines using multi-region sampling revealing intra-tumor heterogeneity of gallbladder carcinoma.
    Feng F; Cheng Q; Li B; Liu C; Wang H; Li B; Xu X; Yu Y; Chen Z; Wu X; Dong H; Chu K; Xie Z; Gao Q; Xiong L; Li F; Yi B; Zhang D; Jiang X
    Hum Cell; 2021 May; 34(3):918-931. PubMed ID: 33813726
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preliminary screening and identification of stem cell-like sphere clones in a gallbladder cancer cell line GBC-SD.
    Yin BB; Wu SJ; Zong HJ; Ma BJ; Cai D
    J Zhejiang Univ Sci B; 2011 Apr; 12(4):256-63. PubMed ID: 21462380
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Integrative molecular characterisation of gallbladder cancer reveals micro-environment-associated subtypes.
    Nepal C; Zhu B; O'Rourke CJ; Bhatt DK; Lee D; Song L; Wang D; Van Dyke AL; Choo-Wosoba H; Liu Z; Hildesheim A; Goldstein AM; Dean M; LaFuente-Barquero J; Lawrence S; Mutreja K; Olanich ME; Lorenzo Bermejo J; ; Ferreccio C; Roa JC; Rashid A; Hsing AW; Gao YT; Chanock SJ; Araya JC; Andersen JB; Koshiol J
    J Hepatol; 2021 May; 74(5):1132-1144. PubMed ID: 33276026
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Variants in ABCG8 and TRAF3 genes confer risk for gallstone disease in admixed Latinos with Mapuche Native American ancestry.
    Bustos BI; Pérez-Palma E; Buch S; Azócar L; Riveras E; Ugarte GD; Toliat M; Nürnberg P; Lieb W; Franke A; Hinz S; Burmeister G; von Schönfels W; Schafmayer C; Völzke H; Völker U; Homuth G; Lerch MM; Santos JL; Puschel K; Bambs C; Roa JC; Gutiérrez RA; Hampe J; De Ferrari GV; Miquel JF
    Sci Rep; 2019 Jan; 9(1):772. PubMed ID: 30692554
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long non-coding RNA SSTR5-AS1 facilitates gemcitabine resistance via stabilizing NONO in gallbladder carcinoma.
    Xue Z; Yang B; Xu Q; Zhu X; Qin G
    Biochem Biophys Res Commun; 2020 Feb; 522(4):952-959. PubMed ID: 31810606
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potential biomarkers for sensitivity of gallbladder cancer cells to gemcitabine.
    Yang C; Xu M; Shen HJ; Zhu HY; Li F; He M; Chen T; Wang J; Shi WJ; Ji F
    Int J Clin Exp Pathol; 2014; 7(2):521-8. PubMed ID: 24551272
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ABCB1/4 gallbladder cancer risk variants identified in India also show strong effects in Chileans.
    Boekstegers F; Marcelain K; Barahona Ponce C; Baez Benavides PF; Müller B; de Toro G; Retamales J; Barajas O; Ahumada M; Morales E; Rojas A; Sanhueza V; Loader D; Rivera MT; Gutiérrez L; Bernal G; Ortega A; Montalvo D; Portiño S; Bertrán ME; Gabler F; Spencer L; Olloquequi J; González Silos R; Fischer C; Scherer D; Jenab M; Aleksandrova K; Katzke V; Weiderpass E; Moradi T; Fischer K; Bossers W; Brenner H; Hveem K; Eklund N; Völker U; Waldenberger M; Fuentes Guajardo M; Gonzalez-Jose R; Bedoya G; Bortolini MC; Canizales S; Gallo C; Ruiz Linares A; Rothhammer F; Lorenzo Bermejo J
    Cancer Epidemiol; 2020 Apr; 65():101643. PubMed ID: 32058310
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genomic
    Li M; Liu F; Zhang F; Zhou W; Jiang X; Yang Y; Qu K; Wang Y; Ma Q; Wang T; Bai L; Wang Z; Song X; Zhu Y; Yuan R; Gao Y; Liu Y; Jin Y; Li H; Xiang S; Ye Y; Zhang Y; Jiang L; Hu Y; Hao Y; Lu W; Chen S; Gu J; Zhou J; Gong W; Zhang Y; Wang X; Liu X; Liu C; Liu H; Liu Y; Liu Y
    Gut; 2019 Jun; 68(6):1024-1033. PubMed ID: 29954840
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Establishment and characterization of a novel highly aggressive gallbladder cancer cell line, TJ-GBC2.
    Liu ZY; Xu GL; Tao HH; Yang YQ; Fan YZ
    Cancer Cell Int; 2017; 17():20. PubMed ID: 28194091
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circular RNA circERBB2 promotes gallbladder cancer progression by regulating PA2G4-dependent rDNA transcription.
    Huang X; He M; Huang S; Lin R; Zhan M; Yang D; Shen H; Xu S; Cheng W; Yu J; Qiu Z; Wang J
    Mol Cancer; 2019 Nov; 18(1):166. PubMed ID: 31752867
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hispidulin inhibits proliferation and enhances chemosensitivity of gallbladder cancer cells by targeting HIF-1α.
    Gao H; Xie J; Peng J; Han Y; Jiang Q; Han M; Wang C
    Exp Cell Res; 2015 Mar; 332(2):236-46. PubMed ID: 25499970
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overexpression of microRNA-205-5p exerts suppressive effects on stem cell drug resistance in gallbladder cancer by down-regulating PRKCE.
    Zhang GF; Wu JC; Wang HY; Jiang WD; Qiu L
    Biosci Rep; 2020 Sep; 40(9):. PubMed ID: 32869841
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stepwise correlation of TP53 mutations from pancreaticobiliary maljunction to gallbladder carcinoma: a retrospective study.
    Kawakami S; Takano S; Fukasawa M; Shindo H; Takahashi E; Fukasawa Y; Hayakawa H; Kuratomi N; Kadokura M; Hosomura N; Amemiya H; Kawaida H; Kono H; Maekawa S; Ichikawa D; Enomoto N
    BMC Cancer; 2021 Nov; 21(1):1245. PubMed ID: 34798839
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inflammatory profiles in Chilean Mapuche and non-Mapuche women with gallstones at risk of developing gallbladder cancer.
    Jackson SS; Van De Wyngard V; Pfeiffer RM; Cook P; Hildesheim A; Pinto LA; Jackson SH; Choi K; Verdugo RA; Cuevas M; Yáñez C; Tobar-Calfucoy E; Retamales-Ortega R; Araya JC; Ferreccio C; Koshiol J
    Sci Rep; 2021 Feb; 11(1):3686. PubMed ID: 33574564
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genome-wide CRISPR screen identifies ELP5 as a determinant of gemcitabine sensitivity in gallbladder cancer.
    Xu S; Zhan M; Jiang C; He M; Yang L; Shen H; Huang S; Huang X; Lin R; Shi Y; Liu Q; Chen W; Mohan M; Wang J
    Nat Commun; 2019 Dec; 10(1):5492. PubMed ID: 31792210
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pretreatment with Gemcitabine/5-Fluorouracil Enhances the Cytotoxicity of Trastuzumab to HER2-Negative Human Gallbladder Cancer Cells In Vitro and In Vivo.
    Wang W; Hu Z; Huang Y; Zheng H; Sun Q; Yang Q; Zhang Y; Zhang L; Wang W
    Biomed Res Int; 2019; 2019():9205851. PubMed ID: 31019975
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MiR-31 regulates the cisplatin resistance by targeting Src in gallbladder cancer.
    Li M; Chen W; Zhang H; Zhang Y; Ke F; Wu X; Zhang Y; Weng M; Liu Y; Gong W
    Oncotarget; 2016 Dec; 7(50):83060-83070. PubMed ID: 27825112
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cordycepin down-regulates multiple drug resistant (MDR)/HIF-1α through regulating AMPK/mTORC1 signaling in GBC-SD gallbladder cancer cells.
    Wu WD; Hu ZM; Shang MJ; Zhao DJ; Zhang CW; Hong DF; Huang DS
    Int J Mol Sci; 2014 Jul; 15(7):12778-90. PubMed ID: 25046749
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Loss of NDRG2 promotes epithelial-mesenchymal transition of gallbladder carcinoma cells through MMP-19-mediated Slug expression.
    Lee DG; Lee SH; Kim JS; Park J; Cho YL; Kim KS; Jo DY; Song IC; Kim N; Yun HJ; Park YJ; Lee SJ; Lee HG; Bae KH; Lee SC; Shim S; Kim YM; Kwon YG; Kim JM; Lee HJ; Min JK
    J Hepatol; 2015 Dec; 63(6):1429-39. PubMed ID: 26292259
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.